105 related articles for article (PubMed ID: 15650004)
1. Molecular evaluation of antibiotic susceptibility of Tropheryma whipplei in axenic medium.
Boulos A; Rolain JM; Mallet MN; Raoult D
J Antimicrob Chemother; 2005 Feb; 55(2):178-81. PubMed ID: 15650004
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of pentamidine against Tropheryma whipplei.
Rolain JM; Fenollar F; Raoult D
Int J Antimicrob Agents; 2011 Dec; 38(6):545-7. PubMed ID: 22005072
[TBL] [Abstract][Full Text] [Related]
3. Failure and relapse after treatment with trimethoprim/sulfamethoxazole in classic Whipple's disease.
Lagier JC; Fenollar F; Lepidi H; Raoult D
J Antimicrob Chemother; 2010 Sep; 65(9):2005-12. PubMed ID: 20639526
[TBL] [Abstract][Full Text] [Related]
4. Acquired resistance to trimethoprim-sulfamethoxazole during Whipple disease and expression of the causative target gene.
Bakkali N; Fenollar F; Biswas S; Rolain JM; Raoult D
J Infect Dis; 2008 Jul; 198(1):101-8. PubMed ID: 18500934
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic susceptibility of Tropheryma whipplei in MRC5 cells.
Boulos A; Rolain JM; Raoult D
Antimicrob Agents Chemother; 2004 Mar; 48(3):747-52. PubMed ID: 14982759
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic susceptibilities of Legionella pneumophila strain Paris in THP-1 cells as determined by real-time PCR assay.
Roch N; Maurin M
J Antimicrob Chemother; 2005 Jun; 55(6):866-71. PubMed ID: 15883178
[TBL] [Abstract][Full Text] [Related]
7. Resistance to trimethoprim/sulfamethoxazole and Tropheryma whipplei.
Fenollar F; Rolain JM; Alric L; Papo T; Chauveheid MP; van de Beek D; Raoult D
Int J Antimicrob Agents; 2009 Sep; 34(3):255-9. PubMed ID: 19346107
[TBL] [Abstract][Full Text] [Related]
8. Treatment of classic Whipple's disease: from in vitro results to clinical outcome.
Lagier JC; Fenollar F; Lepidi H; Giorgi R; Million M; Raoult D
J Antimicrob Chemother; 2014 Jan; 69(1):219-27. PubMed ID: 23946319
[TBL] [Abstract][Full Text] [Related]
9. Tropheryma whipplei glycosylation in the pathophysiologic profile of Whipple's disease.
Bonhomme CJ; Renesto P; Desnues B; Ghigo E; Lepidi H; Fourquet P; Fenollar F; Henrissat B; Mege JL; Raoult D
J Infect Dis; 2009 Apr; 199(7):1043-52. PubMed ID: 19222368
[TBL] [Abstract][Full Text] [Related]
10. [From Whipple's disease to Tropheryma whipplei infections].
Lagier JC; Fenollar F; Raoult D
Med Mal Infect; 2010 Jul; 40(7):371-82. PubMed ID: 20079990
[TBL] [Abstract][Full Text] [Related]
11. Global proteomic pattern of Tropheryma whipplei: a Whipple's disease bacterium.
Kowalczewska M; Villard C; Lafitte D; Fenollar F; Raoult D
Proteomics; 2009 Mar; 9(6):1593-616. PubMed ID: 19253299
[TBL] [Abstract][Full Text] [Related]
12. [Whipple's disease with normal duodenal histology and ankylosing spondylitis].
Ahmadi-Simab K; Schnitzler P
Dtsch Med Wochenschr; 2009 Jan; 134(4):127-30. PubMed ID: 19148854
[TBL] [Abstract][Full Text] [Related]
13. Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple's disease.
Lagier JC; Fenollar F; Lepidi H; Raoult D
J Antimicrob Chemother; 2011 May; 66(5):1188-9. PubMed ID: 21393129
[No Abstract] [Full Text] [Related]
14. Bacterial profile and drug susceptibility pattern of urinary tract infection in pregnant women at Tikur Anbessa Specialized Hospital Addis Ababa, Ethiopia.
Assefa A; Asrat D; Woldeamanuel Y; G/Hiwot Y; Abdella A; Melesse T
Ethiop Med J; 2008 Jul; 46(3):227-35. PubMed ID: 19271386
[TBL] [Abstract][Full Text] [Related]
15. Cultivation of Tropheryma whipplei from cerebrospinal fluid.
Maiwald M; von Herbay A; Fredricks DN; Ouverney CC; Kosek JC; Relman DA
J Infect Dis; 2003 Sep; 188(6):801-8. PubMed ID: 12964110
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of Bartonella species to 17 antimicrobial compounds: comparison of Etest and agar dilution.
Dörbecker C; Sander A; Oberle K; Schülin-Casonato T
J Antimicrob Chemother; 2006 Oct; 58(4):784-8. PubMed ID: 16916864
[TBL] [Abstract][Full Text] [Related]
17. Erythema nodosum-like lesions in treated Whipple's disease: signs of immune reconstitution inflammatory syndrome.
Schaller J; Carlson JA
J Am Acad Dermatol; 2009 Feb; 60(2):277-88. PubMed ID: 19150271
[TBL] [Abstract][Full Text] [Related]
18. In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis.
Alhanout K; Brunel JM; Raoult D; Rolain JM
J Antimicrob Chemother; 2009 Oct; 64(4):810-4. PubMed ID: 19666647
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
20. A survey of antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae in Turkey, 2004 2005.
Sener B; Tunçkanat F; Ulusoy S; Tünger A; Söyletir G; Mülazimoğlu L; Gürler N; Oksüz L; Köksal I; Aydin K; Yalçin AN; Oğünç D; Acar A; Sievers J
J Antimicrob Chemother; 2007 Sep; 60(3):587-93. PubMed ID: 17597058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
